1834P Febrile neutropenia outside of clinical trials in intermediate-risk patients receiving chemotherapy: A MASCC neutropenia, infection and myelosuppression study group-prospective, real-world study

Authors :: Carme Font
Marianne Paesmans
H.R. Kourie
M. Garcia-Morillo
R. Popescu
N. Mathieson
A.A. Jabbar
J.G. Gomez
Z. Samoon
A. Kayumba
Andriy Krendyukov
L. Heyman
F. Esposito
Bernardo Leon Rapoport
Jean Klastersky
Source :: Annals of Oncology. 31:S1055
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Hematology
Neutropenia
medicine.disease
Clinical trial
Oncology
Internal medicine
medicine
business
Intermediate risk
Febrile neutropenia

Full Text Access

Tools